Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 3
1(20.0%)
5Total
N/A(4)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05838651Not ApplicableActive Not Recruiting

Socket Preservation With BioHorizon's Striate+ Membrane and MinerOss X Plug

Role: collaborator

NCT05804253Not ApplicableCompleted

Maxillary Sinus Grafting With Deproteinized Porcine or Bovine Bone Mineral.

Role: lead

NCT05711147Phase 3Unknown

One-time Abutment Placement Versus 4 Times Abutment Removal Around Dental Implants

Role: collaborator

NCT03558347Not ApplicableUnknown

CF41102 5-year Clinical Evaluation of Conelog® Implant With 7 mm Length

Role: collaborator

NCT04243460Not ApplicableCompleted

Influence of Soft Tissue Thickness on the Bone Level Around Implants

Role: collaborator

All 5 trials loaded